These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1462 related items for PubMed ID: 7559897

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH, Barnes KM, Cutler GB.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
    [Abstract] [Full Text] [Related]

  • 65. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM, Borondy M, Markovs ME, Hopwood NJ, Kletter GB, Beitins IZ.
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [Abstract] [Full Text] [Related]

  • 66. Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.
    Chang HP, Yang SF, Wang SL, Su PH.
    BMC Endocr Disord; 2018 Sep 19; 18(1):66. PubMed ID: 30249230
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Central precocious puberty: treatment with triptorelin 11.25 mg.
    Chiocca E, Dati E, Baroncelli GI, Cassio A, Wasniewska M, Galluzzi F, Einaudi S, Cappa M, Russo G, Bertelloni S.
    ScientificWorldJournal; 2012 Sep 19; 2012():583751. PubMed ID: 22645436
    [Abstract] [Full Text] [Related]

  • 71. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
    Cohick WS, Armstrong JD, Whitacre MD, Lucy MC, Harvey RW, Campbell RM.
    Endocrinology; 1996 May 19; 137(5):1670-7. PubMed ID: 8612500
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep 19; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 74. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F, Pescovitz OH, Rieth KG, Dwyer AJ, Hench K, McNemar A, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Nov 19; 59(5):888-92. PubMed ID: 6434587
    [Abstract] [Full Text] [Related]

  • 75. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May 19; 290(5):E1006-13. PubMed ID: 16390864
    [Abstract] [Full Text] [Related]

  • 76. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments.
    Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S.
    Acta Paediatr; 1994 Oct 19; 83(10):1052-6. PubMed ID: 7841703
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche.
    Teixeira RJ, Silva VC, Gazolla HM, Cunha SB, Guimarães MM.
    J Pediatr Endocrinol Metab; 2002 Jan 19; 15(1):69-75. PubMed ID: 11826868
    [Abstract] [Full Text] [Related]

  • 79. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V, Fulghesu AM, la Marca A, Morgante G, Pasqui L, Talluri B, Torricelli M, Caruso A.
    Gynecol Endocrinol; 2000 Dec 19; 14(6):411-6. PubMed ID: 11228061
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 74.